Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series-Reference-Cited by-同舟云学术

Association between the interleukin 23 receptor and ankylosing spondylitis is confirmed by a new UK case-control study and meta-analysis of published series

Published:2009-01-30 Issue:4 Volume:48 Page:386-389
ISSN:1462-0324
Container-title:Rheumatology
language:en
Short-container-title:Rheumatology

Author:

Karaderi T.,Harvey D.,Farrar C.,Appleton L. H.,Stone M. A.,Sturrock R. D.,Brown M. A.,Wordsworth P.,Pointon J. J.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/48/4/386/5062772/ken501.pdf

Reference15 articles.

1. Genetic aspects of susceptibility, severity, and clinical expression in ankylosing spondylitis

2. Ankylosing spondylitis

3. Breakthroughs in genetic studies of ankylosing spondylitis

4. A Receptor for the Heterodimeric Cytokine IL-23 Is Composed of IL-12Rβ1 and a Novel Cytokine Receptor Subunit, IL-23R

5. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Pathogenesis of Spondylarthritis beyond HLA-B27: A Descriptive Review;International Journal of Molecular Sciences;2024-05-31

2. Determination of IL-23 receptor expression and gene polymorphism (rs1884444) in Iranian patients with ankylosing spondylitis;BMC Rheumatology;2024-04-11

3. Comprehensive epigenomic profiling reveals the extent of disease-specific chromatin states and informs target discovery in ankylosing spondylitis;Cell Genomics;2023-06

4. Association of IL-23R (rs11209026 A/G) polymorphism with susceptibility to common autoimmune diseases: a meta-analysis combined with trial sequence analysis;2023-05-09

5. The Inflammatory Factor SNP May Serve as a Promising Biomarker for Acitretin to Alleviate Secondary Failure of Response to TNF-a Monoclonal Antibodies in Psoriasis;Frontiers in Pharmacology;2022-06-24